Donepezil, galantamine and rivastigmine (the acetylcholinesterase - AChE - inhibitors) can now be used in mild disease, as well as in moderate disease. These drugs all work by increasing the level of ACh at sites of neurotransmission.
Memantine can be used in moderate disease if patients can't take AChE inhibitors. It can also be used in severe disease. Memantine is a (wait for it!) voltage-dependent, moderate-affinity, uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. Basically, there are increased levels of glutamate seen at neurotransmitter sites. Memantine blocks the effects of this increased glutamate.
Conditions for use
- Specialist use only
- They should only be continued of there is improvement in cognition or global, functional or behavioural symptoms.
- For AChE inhibitors, taking into account individual needs, the lowest acquisition drug should be used.
Latest posts by Louise Hudman (see all)
- Nice | Who should we be testing for cirrhosis? - October 3, 2016
- Nice | Non-alcoholic fatty liver disease NAFLD - August 26, 2016
- Evolocumab and Alirocumab for treating dyslipidaemia - August 25, 2016